StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
AcelRx Pharma (ACRX) shares on watch as FDA briefing docs released
October 10, 2018 8:05 AM
AcelRx Pharma (NASDAQ ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
FDA
Trader Talk
Next Articles
AcelRx Pharma's (ACRX) Pain-Killer Dsuvia Wins FDA Panel Backing, Vote 10-3 to Support Approval - Bloomberg
October 12, 2018 2:53 PM
AcelRx Pharma (ACRX) Stock Trading Halted Ahead of FDA Advisory Committee to Review DSUVIA NDA
October 12, 2018 7:11 AM
AcelRx Pharma (ACRX) Halted, News Pending
October 12, 2018 6:55 AM
AcelRx (ACRX) Briefing Docs Bode Well for Vote - H.C. Wainwright
October 10, 2018 12:30 PM
AcelRx (ACRX) Briefing Docs 'Positive', Expect Favorable Vote - Oppenheimer
October 10, 2018 12:24 PM
AcelRx (ACRX) Could Have Positive AdCom Vote - Cantor Fitzgerald
October 10, 2018 9:45 AM
